Trial Profile
Periarticular Infusion With Liposomal Bupivacaine or a Ropivacaine Cocktail Versus Continuous Femoral Nerve Catheters for Multimodal Pain Management Following Primary TKA: A Randomized Controlled Trial
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 18 Aug 2023
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 14 Aug 2023 Upper age limit added for inclusion criteria as 90 years, thus including elderly participant also.
- 30 Aug 2017 Status changed from active, no longer recruiting to discontinued.
- 28 Feb 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.